BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20363214)

  • 1. Urocortins in heart failure.
    Venkatasubramanian S; Newby DE; Lang NN
    Biochem Pharmacol; 2010 Aug; 80(3):289-96. PubMed ID: 20363214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urocortins in heart failure and ischemic heart disease.
    Boonprasert P; Lailerd N; Chattipakorn N
    Int J Cardiol; 2008 Jul; 127(3):307-12. PubMed ID: 18180061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urocortin: molecular biology and cardiovascular effects].
    Raddino R; Pedrinazzi C; Zanini G; Robba D; Bonadei I; Scarabelli TM; Cas LD
    G Ital Cardiol (Rome); 2007 Apr; 8(4):236-45. PubMed ID: 17506295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of urocortins to cardiovascular disease.
    Emeto TI; Moxon JV; Rush C; Woodward L; Golledge J
    J Mol Cell Cardiol; 2011 Sep; 51(3):299-307. PubMed ID: 21689660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new potential approach to inotropic therapy in the treatment of heart failure: urocortin.
    Garg V; Frishman WH
    Cardiol Rev; 2013; 21(3):160-5. PubMed ID: 23269034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma urocortin 1 in human heart failure.
    Wright SP; Doughty RN; Frampton CM; Gamble GD; Yandle TG; Richards AM
    Circ Heart Fail; 2009 Sep; 2(5):465-71. PubMed ID: 19808377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of urocortins in the cardiovascular system.
    Walczewska J; Dzieza-Grudnik A; Siga O; Grodzicki T
    J Physiol Pharmacol; 2014 Dec; 65(6):753-66. PubMed ID: 25554979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family.
    Davidson SM; Rybka AE; Townsend PA
    Biochem Pharmacol; 2009 Jan; 77(2):141-50. PubMed ID: 18817752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma urocortin 1 in sheep: regional sampling and effects of experimental heart failure.
    Charles CJ; Rademaker MT; Richards AM; Yandle TG
    Peptides; 2006 Jul; 27(7):1801-5. PubMed ID: 16442669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urocortins: Actions in health and heart failure.
    Rademaker MT; Richards AM
    Clin Chim Acta; 2017 Nov; 474():76-87. PubMed ID: 28887029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac dysfunction in heart failure: the cardiologist's love affair with time.
    Brutsaert DL
    Prog Cardiovasc Dis; 2006; 49(3):157-81. PubMed ID: 17084177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure.
    Rademaker MT; Cameron VA; Charles CJ; Richards AM
    Circulation; 2005 Dec; 112(23):3624-32. PubMed ID: 16330704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urocortin 2 in cardiovascular health and disease.
    Adão R; Santos-Ribeiro D; Rademaker MT; Leite-Moreira AF; Brás-Silva C
    Drug Discov Today; 2015 Jul; 20(7):906-14. PubMed ID: 25748088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma urocortin in human systolic heart failure.
    Ng LL; Loke IW; O'Brien RJ; Squire IB; Davies JE
    Clin Sci (Lond); 2004 Apr; 106(4):383-8. PubMed ID: 14651473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inflammatory markers in heart failure].
    Ozmen N; Cebeci BS; Kardeşoğlu E
    Anadolu Kardiyol Derg; 2006 Mar; 6(1):51-4. PubMed ID: 16524802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of stress associated peptide Urocortin in heart failure patients.
    Gruson D; Ahn SA; Ketelslegers JM; Rousseau MF
    Peptides; 2010 Feb; 31(2):354-6. PubMed ID: 19961889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.